GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
$1.30
+0 (+0%)
At Close: Jan 09, 2024
Forecast Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Information

80 West Lancaster Avenue, Suite 300

Devon PA 19333

484 581 7505

www.zynerba.com

Zynerba Pharmaceuticals

Description

Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania.

Click to get the best stock tips daily for free!

About Zynerba Pharmaceuticals

Zynerba Pharmaceuticals Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba P... ZYNE Profile

Golden Star

Ticker Date Change Price
ITCI Apr 05 12.05% $68.44
AKR Apr 05 0.665% $16.53
SARK Mar 28 16.07% $26.88
ARCC Mar 25 1.04% $20.12
STT Mar 19 0.262% $72.62
GGB Mar 19 0.468% $4.27
CAG Mar 18 7.16% $28.22
JBI Mar 15 1.29% $14.72
MASI Mar 14 3.34% $132.20
CMC Mar 14 5.04% $53.19
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT